-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - Layout 1
Introduction
Clostridium difficile infection (CDI) is a
serious healthcare-associated infection and
a growing health care problem. C. difficile
is a Gram-positive, spore-forming,
anaerobic bacterium that, when ingested,
can cause CDI if it is a toxigenic strain.
CDI symptoms include varying levels of
diarrh…
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table A-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
May 01, 2022 - Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings
Rapid Evidence Product
October 2, 2020
No-Touch Modalities for Disinfecting
Patient Rooms in Acute Care Settings
Background and Purpose
Purpose of Review
To rapidly identify evidence assessing the effect of no-to…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
January 01, 2013 - CER #60:
Treatment for Glaucoma: Comparative Effectiveness
Original release date:
April, 2012
Surveillance Report:
May, 2013
Key Findings:
- A large number of relatively small new studies were
identified that compared the effectiveness and safety of
existing treatments but none sufficiently challenge…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
April 09, 2020 - Appendix Table B-1. RCTs of Masks
B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/U…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - Appendix E-1
Appendix E-1. Data Abstraction of Study Characteristics
Table E-1-1
Table E-1-1. Study characteristics of RCTs addressing Key Questions 1 and 2
Key Question Author, Year
Country
Quality Rating Demographics and Baseline Characteristics Other Population Characteristics Reason fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
May 01, 2025 - Association Between Outcomes and Dental Services in People With Substance Use Disorder: A Rapid Response Review
Rapid Evidence Product
Association Between Outcomes and Dental Services
in People With Substance Use Disorder: A Rapid
Response Review
Prepared for:
Agency for Healthcare Research and Quality
U.S. D…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - Finding Evidence for Comparing Medical Interventions
Methods Guide for
Comparative Effectiveness Reviews
Finding Evidence for Comparing Medical
Interventions
Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness,
comparative effectiveness, an…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
January 01, 2018 - Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition
Research White Paper
Registries in Accountable Care
Research White Paper
Registries in Accountable Care
Addendum to Registries for Evaluating Patient Outcomes: A
User’s Guide, Third Edition…
-
effectivehealthcare.ahrq.gov/health-topics/obesity-children
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - Methods Research Report
Development of Quality Criteria To Evaluate
Nontherapeutic Studies of Incidence, Prevalence, or
Risk Factors of Chronic Diseases: Pilot Study of New
Checklists
This report is based on research conducted by the Minnesota Evidence-based Practice Center
und…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 108
Migraine in Children:
Preventive Pharmacologic Treatments
Executive Summary
Introduction
The Agency for Healthcare Research
and Quality (AHRQ) commissioned the
Minnesota Evidence-based Practice
Center (EPC) to conduct a review of
preventive pharmacologic treatm…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
December 01, 2011 - Layout 1
Background
Coronary stents and adjunctive
pharmacologic agents—including
glycoprotein IIb/IIIa receptor inhibitors and
thienopyridines—have improved the
efficacy of percutaneous coronary
intervention (PCI).1,2 However,
dislodgement of atherothrombotic material
from coronary lesions during PCI can
result in …
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - Layout 1
Background
Cystic fibrosis (CF) is the second most
common life-shortening, childhood-onset
genetic disease in the United States,
affecting approximately 30,000 people in
the Nation. The gene responsible for CF
encodes the cystic fibrosis transmembrane
regulator (CFTR) protein, which regulates
sodium and chl…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review
Purpose of Review
To summarize the effects of long-term osteoporosis
drug treatment and of osteoporosis drug treatment
discontinuation and holidays.
Key Messages
• Evidence on the effects …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults
Making Healthcare Safer IV
Deprescribing To Reduce Medication
Harms in Older Adults
Rapid Response
Main Points
• Deprescribing has emerged as a clinical practice to reduce polypharmacy and
use of potenti…